Stryker (SYK) Stock: Buy, Sell, or Hold?
SYK - Stryker Corporation
$278.20
-7.02 (-2.46%)
▼
5d:
-0.2%
30d:
-8.22%
90d:
-14.88%
BUY
HIGH Confidence
Analysis Updated: Oct 6, 2026 12:00 AM ET
Earnings: Oct 29, 2026
21d
Get Alerted When SYK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SYK appears deeply undervalued. Market expects -6.4% annual earnings decline despite 44% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: SYK appears deeply undervalued. Market expects -6.4% annual earnings decline despite 44% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$491.90
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$305.43
8.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SYK is currently trading at $278.20, which is considered fair relative to its 30-day fair value range of $267.93 to $302.59. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.6) compared to its historical average (20.3). Remarkably, the market is currently pricing in an annual earnings decline of 6.4% over the next few years. This pessimistic expectation contrasts with the company's recent 44.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SYK is in a downtrend. The price is approaching resistance at $286.09. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SYK scores 71/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $367.00 (+31.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SYK is in a downtrend. The price is approaching resistance at $286.09. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SYK scores 71/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $367.00 (+31.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$267.93 -
$302.59
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (71/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.9% below Wall St target ($367.00)
- BULLISH: Bottoming setup score 71/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$267.93 -
$302.59
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$268.69
Resistance Level
$286.09
Current Trend
Downtrend
Technical data as of
Oct 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.65
Wall Street Target
$367.00
(+31.9%)
Revenue Growth (YoY)
9.4%
Earnings Growth (YoY)
44.1%
Profit Margin
14.4%
Valuation Discount vs History
-6.4% cheaper
PE vs Historical
16.7 vs 20.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.4%
(market-implied from PE analysis)
1-Year Target
$260.40
(-6%)
2-Year Target
$243.73
(-12%)
3-Year Target
$228.13
(-18%)
3-Yr Target (if PE normalizes)
(PE: 17→20)
$278.15
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.7, Growth: 11.5%)
$456.57
(+64%)
Base:
(SPY PE: 16.6, Growth: 11.5%)
$385.87
(+39%)
Bear:
(PE: 14.2, Growth: 11.5%)
$327.99
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 29.56 | Current EPS (TTM): $9.65
Bull Case
$543.25
(+95%)
Analyst growth 73.2%, PE expands to 32.5
Base Case
$493.87
(+78%)
Market implied 73.2%, PE stable at 29.6
Bear Case
$193.95
(-30%)
Severe decline -20.0%, PE contracts to 25.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.6 to 20.3
Stabilization Target:
$339.20
(+21.9%)
PE Expansion Potential:
+21.9%
Share & Embed Analysis
Last updated: October 06, 2026 11:25 PM ET
Data refreshes hourly during market hours. Next update: 12:25 AM
Data refreshes hourly during market hours. Next update: 12:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SYK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$101 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$121 | 60 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
28 analysts |
$95 | 40 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
20 analysts |
$83 | 60 BUY |
|
GKOS
Glaukos Corp |
STRONG BUY
14 analysts |
$199 | 71 BUY |
Advanced SYK Option Strategies
Professional options setups generated by AI based on today's SYK price and gamma walls.
